These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 30668617)
1. Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary Tract. Sassa N; Iwata H; Kato M; Murase Y; Seko S; Nishikimi T; Hattori R; Gotoh M; Tsuzuki T Am J Clin Pathol; 2019 Apr; 151(5):469-478. PubMed ID: 30668617 [TBL] [Abstract][Full Text] [Related]
2. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH. Vlajnic T; Gut A; Savic S; Bubendorf L J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041 [TBL] [Abstract][Full Text] [Related]
3. Utility of The Paris System (TPS) for upper urinary tract cytopathology: correlation with histology follow-up and UroVysion fluorescence in situ hybridization (FISH) analysis. Jia L; Rood T; Kirkpatrick J; Sarode V J Am Soc Cytopathol; 2024; 13(2):149-155. PubMed ID: 38341300 [TBL] [Abstract][Full Text] [Related]
4. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion Miki Y; Neat M; Chandra A Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215 [TBL] [Abstract][Full Text] [Related]
5. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection. Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368 [TBL] [Abstract][Full Text] [Related]
6. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology. Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961 [TBL] [Abstract][Full Text] [Related]
7. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas. McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548 [TBL] [Abstract][Full Text] [Related]
8. Urinary cytology with acridine orange fluorescence is highly valuable for predicting high-grade upper urinary tract urothelial carcinoma. Li J; Zhang Z; Wang J; Zhang C; Li H; Xu Y Int J Clin Exp Pathol; 2014; 7(2):774-8. PubMed ID: 24551302 [TBL] [Abstract][Full Text] [Related]
9. UroVysion Iwata H; Sassa N; Kato M; Murase Y; Seko S; Kawanishi H; Hattori R; Gotoh M; Tsuzuki T Int J Clin Oncol; 2021 Jan; 26(1):178-185. PubMed ID: 32959230 [TBL] [Abstract][Full Text] [Related]
10. Two-year study on the application of the Paris system for urinary cytology in a cancer centre. de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587 [TBL] [Abstract][Full Text] [Related]
11. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study. Danakas A; Sweeney M; Cheris S; Agrawal T J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054 [TBL] [Abstract][Full Text] [Related]
12. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system. Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811 [TBL] [Abstract][Full Text] [Related]
13. Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results. McHale T; Ohori NP; Cieply KM; Sherer C; Bastacky SI Diagn Cytopathol; 2019 Apr; 47(4):282-288. PubMed ID: 30417563 [TBL] [Abstract][Full Text] [Related]
14. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology. Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848 [TBL] [Abstract][Full Text] [Related]
15. Vysis UroVysion for the detection of urothelial carcinoma. Halling KC Expert Rev Mol Diagn; 2003 Jul; 3(4):507-19. PubMed ID: 12877389 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126 [TBL] [Abstract][Full Text] [Related]
17. Utility of fluorescence Yu J; Xiong H; Wei C; Cui Z; Jin X; Zhang J J Cancer Res Ther; 2017; 13(4):647-650. PubMed ID: 28901308 [TBL] [Abstract][Full Text] [Related]
18. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Luo B; Li W; Deng CH; Zheng FF; Sun XZ; Wang DH; Dai YP Cancer Genet Cytogenet; 2009 Mar; 189(2):93-7. PubMed ID: 19215789 [TBL] [Abstract][Full Text] [Related]
19. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma. Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830 [TBL] [Abstract][Full Text] [Related]
20. The utility of upper urinary tract urine cytology before and after application of the Paris system. Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]